Clinical Trial Update: NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies [Phase 2]

View source ↗

Summary

Phase 2 study evaluating NP137 for clinical and biological activity in patients with advanced or metastatic solid tumors treated with standard PD-1/PD-L1 immuno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• NP137

Snippet

Sponsor: Centre Leon Berard | Conditions: Advanced Solid Tumors, Metastatic Solid Tumors | Phase 2 | Status: ACTIVE_NOT_RECRUITING